COFORGE Ltd Valuation Analysis Report April 2026
Coforge Limited (formerly NIIT Technologies) is a global IT services and digital solutions company headquartered in Noida, India. Rebranded in 2020, Coforge delivers application development, cloud computing, business process outsourcing, infrastructure management, and AI/ML-led transformation services. The company employs over 35,000 professionals across 25 countries with 33 global delivery centres.
Coforge focuses on select verticals — Banking, Financial Services & Insurance (BFSI), Travel & Hospitality, Healthcare, Hi-Tech, and Retail — embedding deep domain expertise with modern engineering. The Sabre (airline GDS) relationship remains a flagship strategic anchor, while the Cigniti acquisition (testing/QA specialist) and the pending Encora deal (US-based digital engineering, ~$2.35 Bn) are transforming Coforge into a larger, full-spectrum digital engineering platform.
The company’s proprietary AI platform, ForgeX, is now in enterprise deployment with a global airline and a US financial services client, marking the transition from AI pilots to scaled commercial delivery — a key differentiator in a crowded market.
| Metric (₹ Cr) | FY22 | FY23 | FY24 | FY25 | FY26E |
|---|---|---|---|---|---|
| Revenue | 5,360 | 7,220 | 9,019 | 12,051 | 16,291 |
| Revenue Growth YoY | — | 34.7% | 24.9% | 33.6% | 35.2% |
| EBITDA | 830 | 1,100 | 1,452 | 1,700 | 2,444 |
| EBITDA Margin | 15.5% | 15.2% | 16.1% | 14.1% | 15.0% |
| EBIT Margin | 12.8% | 11.5% | 11.5% | ~11% | 14.0% |
| PAT | 572 | 710 | 850 | 965 | 1,410 |
| PAT Growth YoY | — | 24.1% | 19.7% | 13.5% | 46.1% |
| EPS (₹) | 18.5 | 23.0 | 27.0 | 30.5 | ~41 |
| FCF Conversion (%PAT) | ~70% | ~72% | ~75% | ~80% | ~85% |
| OCF (₹ Cr) | 480 | 640 | 875 | 1,200 | ~1,700 |
Note: FY26E revenue/PAT from Axis Securities estimates (Jan 2026). FY25 reported PAT includes exceptional items; adjusted PAT per company disclosure. Consolidated basis.
FY25 was exceptional — 32% constant-currency (CC) growth, 14 large deals closed, and a 47.7% YoY jump in the next-twelve-month executable order book to close the year. The step-up in EBITDA margin in FY26E reflects Cigniti integration settling and operating leverage kicking in.
The DCF intrinsic value of ~₹1,580/share implies the stock is modestly undervalued at current levels. Analyst consensus (Axis Securities, ICICI Direct) uses a P/E multiple framework — valuing at 37× FY27E EPS of ₹62 — arriving at ₹2,300. The gap between DCF (~₹1,580) and P/E-based targets (~₹2,300) reflects premium-for-growth assumptions built into sell-side models. A conservative investor should anchor to the DCF band (₹1,420–₹1,760) for entry discipline.
At ₹1,240 — near the bottom of the Accumulate zone — the stock offers a favourable entry point for investors with a 2–3 year view. The 27.6% decline over the past six months (from highs near ₹1,994) has meaningfully de-risked the valuation. The current P/E of ~63× is elevated on a trailing basis but compresses rapidly to ~30× on FY27E earnings, making the growth-adjusted case compelling.
Base case anchors at ₹1,680, implying ~35% upside from CMP. Key triggers for bull case are: (a) EBIT margin crossing 15% in Q4 FY26, (b) Encora regulatory close by April 2026 with no financing surprises, and (c) large deal conversion from the $1.72 Bn NTM order book remaining on track.
| Metric (₹ Cr) | FY25A | FY26E | FY27E | FY28E |
|---|---|---|---|---|
| Revenue | 12,051 | 16,291 | 19,561 | 23,000 |
| Revenue Growth | 33.6% | 35.2% | 20.1% | 17.6% |
| EBIT Margin | ~11% | 14.0% | 15.0% | 16.0% |
| PAT | 965 | 1,410 | 2,030 | 2,580 |
| EPS (₹) | 30.5 | ~41 | ~62 | ~78 |
| P/E on CMP (₹1,240) | 40.7× | 30.2× | 20.0× | 15.9× |
| FY27E P/E (TP ₹1,680) | — | — | 27.1× | 21.5× |
Growth drivers for FY26–FY28 include: (a) Order book conversion — $1.72 Bn NTM executable book at 30% YoY growth provides strong revenue visibility; (b) Encora acquisition — creates a ~$2 Bn Data/Cloud/AI engineering entity, unlocking US mid-market; (c) Vertical momentum — Banking re-accelerating, Healthcare & Hi-Tech nearly doubled YoY, Insurance pipeline converting; (d) ForgeX AI platform — shifting from proof-of-concept billing to outcome-based commercial contracts; and (e) Attrition discipline — 10.9% LTM attrition, among the lowest in the sector, preserving delivery quality and reducing rehiring costs.
Management has explicitly committed to no EPS dilution in FY27 from the Encora deal, with $550 Mn term loan financing secured (no equity dilution). FY27 is guided to be an “exceptional” year — a claim backed by 83% of analysts rating the stock as a Buy.
Source: NSE/BSE data, analyst estimates. Prices as of April 2026.
| Company | Mkt Cap (Cr) | TTM Rev (Cr) | Rev Growth | EBIT Margin | TTM P/E | FY27E P/E | Rating |
|---|---|---|---|---|---|---|---|
| Coforge | 42,700 | ~15,700 | 28–35% | 13.4% | 62.8× | ~20× | ACCUMULATE |
| Persistent Systems | ~71,000 | ~12,500 | ~29% | ~14% | ~68× | ~40× | HOLD |
| LTIMindtree | ~1,32,000 | ~40,000 | ~10% | ~15.5% | ~30× | ~27× | HOLD |
| Mphasis | ~42,000 | ~15,000 | ~8% | ~15% | ~38× | ~32× | HOLD |
| HCL Technologies | ~3,60,000 | ~1,28,000 | ~9% | ~18% | ~22× | ~20× | BUY |
| Sector Avg (IT Services) | — | — | ~12% | ~15% | ~32× | — | — |
Coforge commands a premium valuation versus peers, justified by its superior revenue growth trajectory (28–35% vs. sector ~12%). However, EBIT margins at 13.4% are below sector average (~15%), and the TTM P/E of ~63× is the highest among mid-cap IT peers. The stock’s de-rating from ₹1,994 highs has brought it closer to fair value. Persistent Systems is the closest comparable — similar growth profile but more richly valued. Coforge offers a better risk-adjusted opportunity than Mphasis (slowing growth) and superior growth versus large-caps like HCL at a mid-cap premium.
A Growth Story Temporarily Oversold — But Execution Must Deliver
Coforge’s 27.6% decline from its 52-week peak has created a meaningful entry opportunity. The fundamentals remain intact: a $1.72 Bn NTM executable order book (+30% YoY), industry-low attrition (10.9%), Q3 FY26 revenue at an all-time high of ₹4,188 Cr, and management’s explicit FY27 EPS-neutral commitment on Encora. The ForgeX AI platform is transitioning from pilot to commercial scale — a re-rating trigger if it gains traction.
The key risk is near-term margin pressure and profit volatility. The 33.4% QoQ PAT decline in Q3 FY26 despite strong revenue growth reflects real execution friction — wage inflation, hedge losses, and acquisition-related expenses. Investors must look past FY26 and anchor expectations to FY27E P/E (~20× on CMP), which makes Coforge one of the cheaper high-growth IT names available today.
Accumulate in the ₹1,050–₹1,320 range. Target ₹1,680 over 18–24 months (base case). Bull case ₹2,200 if FY27 margin expansion and Encora synergies materialise ahead of schedule.
